Table of Contents
<< Previous Issue | Sept 2023 (Vol: 2023, Issue: 9) |
- Section: Licensing
-
Immunogen Collaborates with Takeda to Develop and Commercialise Elahere® in Japan
-
Moderna Signs US$1.8 B Oncology Collaboration with Immatics
- Section: Mergers & Acquisitions
-
Regeneron Buys Partner Decibel Therapeutics for Up to US$213 M